LabSolutions CEO Guilty In $187M Telemed Billing Scheme
Jurors returned a guilty verdict Wednesday against the CEO of genetic testing company LabSolutions on accusations of orchestrating a scheme to bill $187 million to Medicare for medically unnecessary genetic testing....To view the full article, register now.
Already a subscriber? Click here to view full article